+

WO2009007411A3 - Inhibition de la formation des ages - Google Patents

Inhibition de la formation des ages Download PDF

Info

Publication number
WO2009007411A3
WO2009007411A3 PCT/EP2008/058954 EP2008058954W WO2009007411A3 WO 2009007411 A3 WO2009007411 A3 WO 2009007411A3 EP 2008058954 W EP2008058954 W EP 2008058954W WO 2009007411 A3 WO2009007411 A3 WO 2009007411A3
Authority
WO
WIPO (PCT)
Prior art keywords
age formation
inhibition
combating
preventing
relates
Prior art date
Application number
PCT/EP2008/058954
Other languages
English (en)
Other versions
WO2009007411A2 (fr
Inventor
Nabil Abdul-Malak
Cécile ALTOBELLI
Eric Perrier
Original Assignee
Basf Beauty Care Solutions France Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Beauty Care Solutions France Sas filed Critical Basf Beauty Care Solutions France Sas
Priority to US12/667,872 priority Critical patent/US20100316743A1/en
Priority to JP2010515507A priority patent/JP2010533142A/ja
Priority to CN200880022985.0A priority patent/CN101686954B/zh
Priority to KR1020157010813A priority patent/KR20150053817A/ko
Priority to BRPI0813926-1A2A priority patent/BRPI0813926A2/pt
Priority to EP08786012A priority patent/EP2170307A2/fr
Publication of WO2009007411A2 publication Critical patent/WO2009007411A2/fr
Publication of WO2009007411A3 publication Critical patent/WO2009007411A3/fr
Priority to US13/668,371 priority patent/US20130078202A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/411—Aromatic amines, i.e. where the amino group is directly linked to the aromatic nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/415—Aminophenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Immunology (AREA)

Abstract

La présente invention concerne l'utilisation d'une substance active favorisant l'inhibition de la formation des AGEs, pour la préparation d'une composition pour prévenir et/ou lutter contre la diminution des propriétés élastiques et plastiques des tissus, et en particulier de la peau, pour inhiber la formation des AGEs, ou pour prévenir et/ou lutter contre la glycation des protéines au niveau cutané. L'invention concerne également une méthode de criblage de telles substances actives.
PCT/EP2008/058954 2007-07-09 2008-07-09 Inhibition de la formation des ages. WO2009007411A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US12/667,872 US20100316743A1 (en) 2007-07-09 2008-07-09 INHIBITION OF THE FORMATION OF AGEs
JP2010515507A JP2010533142A (ja) 2007-07-09 2008-07-09 Ａｇｅの形成の阻害
CN200880022985.0A CN101686954B (zh) 2007-07-09 2008-07-09 Age形成的抑制
KR1020157010813A KR20150053817A (ko) 2007-07-09 2008-07-09 Ａｇｅ 형성의 억제
BRPI0813926-1A2A BRPI0813926A2 (pt) 2007-07-09 2008-07-09 Utilização de uma substância, composição e métodos de triagem de princípios ativos que inibem a formação dos ages e de cuidado cosmético.
EP08786012A EP2170307A2 (fr) 2007-07-09 2008-07-09 Inhibition de la formation des ages.
US13/668,371 US20130078202A1 (en) 2007-07-09 2012-11-05 INHIBITION OF THE FORMATION OF AGEs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0756343 2007-07-09
FR0756343A FR2918569B1 (fr) 2007-07-09 2007-07-09 Substances inhibant la glycation des proteines.

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/668,371 Division US20130078202A1 (en) 2007-07-09 2012-11-05 INHIBITION OF THE FORMATION OF AGEs

Publications (2)

Publication Number Publication Date
WO2009007411A2 WO2009007411A2 (fr) 2009-01-15
WO2009007411A3 true WO2009007411A3 (fr) 2009-11-19

Family

ID=39247375

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/058954 WO2009007411A2 (fr) 2007-07-09 2008-07-09 Inhibition de la formation des ages.

Country Status (8)

Country Link
US (2) US20100316743A1 (fr)
EP (1) EP2170307A2 (fr)
JP (2) JP2010533142A (fr)
KR (2) KR20150053817A (fr)
CN (1) CN101686954B (fr)
BR (1) BRPI0813926A2 (fr)
FR (1) FR2918569B1 (fr)
WO (1) WO2009007411A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2954702B1 (fr) 2009-12-31 2013-07-05 Basf Beauty Care Solutions F Agent stimulant l'expression de loxl
CN102478503A (zh) * 2010-11-25 2012-05-30 苏州卫生职业技术学院 一种检测熊果酸抑制AGEs的作用机制的方法
CN103070400B (zh) * 2012-07-17 2014-01-15 华中农业大学 莲原花青素作为晚期糖基化终产物形成抑制剂的用途
FR2997406B1 (fr) 2012-10-25 2015-07-03 Basf Beauty Care Solutions F Polymere de hyaluronate et de glucomannane
FR3000488B1 (fr) 2012-12-27 2015-10-02 Basf Beauty Care Solutions F Nouveaux derives de l'acide sinapique et leurs utilisations cosmetiques ou pharmaceutiques
CN107125288A (zh) * 2017-05-18 2017-09-05 湖北工业大学 矢车菊素在戚风蛋糕中抑制AGEs的方法
US11484485B2 (en) 2018-06-18 2022-11-01 Elc Management Llc Photostabilizing compounds, compositions, and methods
US11655215B2 (en) 2018-06-18 2023-05-23 Elc Management Llc Photostabilizing compounds, compositions, and methods
CN112533577A (zh) * 2018-06-18 2021-03-19 Elc 管理有限责任公司 光稳定剂化合物、组合物和方法
AU2019289095B2 (en) 2018-06-18 2021-09-23 Elc Management Llc Photostabilizing compounds, compositions, and methods
FR3084256B1 (fr) * 2018-07-27 2021-01-29 Fabre Pierre Dermo Cosmetique Extrait de lespedeza capitata pour son utilisation dans le domaine capillaire
CN115040564A (zh) * 2019-06-11 2022-09-13 百岳特生物技术（上海）有限公司 苦荞麦种皮萃取物减少肌肤上红色斑点数量或面积的用途
WO2021243359A1 (fr) * 2020-05-27 2021-12-02 Mary Kay Inc. Compositions topiques et méthodes
JP2023545001A (ja) 2020-10-05 2023-10-26 クラリアント・インターナシヨナル・リミテツド オオアザミ（Ｓｉｌｙｂｕｍ ｍａｒｉａｎｕｍ）抽出物をセノセラピューティクス剤（ｓｅｎｏｔｈｅｒａｐｅｕｔｉｃ ａｇｅｎｔ）として含む組成物
US11633425B2 (en) 2021-05-13 2023-04-25 Ahava—Dead Sea Laboratories Ltd. Anti-glycation compositions
CN113349233B (zh) * 2021-06-19 2023-04-25 武汉轻工大学 一种营养强化曲奇饼干及其制备方法
CN116725174A (zh) * 2023-06-28 2023-09-12 江南大学 一种基于甘草提取物同时降低热反应肉味香精中AGEs、4-MI和HMF的方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE888635A (fr) * 1980-04-30 1981-08-17 Zenyaku Kogyo Kk Nouvel extrait de plante, procede de preparation, agent immunostimulant comprenant cet extrait comme composant efficace et immunotherapie par son utilisation,
WO1997042957A1 (fr) * 1996-05-15 1997-11-20 Rio Pharmaceuticals Limited Compositions pharmaceutiques comprenant une xanthine et une catechine
WO2003032969A2 (fr) * 2001-10-15 2003-04-24 National Research Council Of Canada Agents anti-glycation destines a la prevention des complications liees a l'age, au diabete et au tabagisme
JP2003212749A (ja) * 2002-01-16 2003-07-30 Noevir Co Ltd ＡＧＥｓ生成抑制剤及びそれを含有する皮膚外用剤
FR2838054A1 (fr) * 2002-04-04 2003-10-10 Rocher Yves Biolog Vegetale Association d'extraits de plantes pour le traitement de la cellulite
EP1683805A1 (fr) * 2003-10-24 2006-07-26 Meiji Seika Kaisha Ltd. Nouvel inhibiteur de formation de produit terminal de glycation avancee et inhibiteur d'aldose reductase
WO2006078848A1 (fr) * 2005-01-21 2006-07-27 Western Holdings, Llc Compositions contenant des extraits botaniques riches en phlorizine et procedes d'utilisation desdites compositions pour modifier le glucose sanguin et agir sur le viellissement
JP2007119373A (ja) * 2005-10-26 2007-05-17 Arkray Inc メイラード反応生成物分解剤およびそれを用いた飲食品

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3502415B2 (ja) * 1993-05-28 2004-03-02 株式会社コーセー メイラード反応阻害剤
JPH10130162A (ja) * 1996-10-31 1998-05-19 Kanebo Ltd ヒアルロン酸分解阻害剤、ヒアルロン酸異常分解疾患治療剤および化粧料
FR2802425B1 (fr) * 1999-12-21 2003-09-26 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des ericaceae comme agent anti-glycation
JP2002053427A (ja) * 2000-08-11 2002-02-19 Maruzen Pharmaceut Co Ltd コラーゲン産生促進剤及びエストロゲン様作用剤並びに皮膚化粧料
US20070003536A1 (en) * 2000-11-21 2007-01-04 Zimmerman Amy C Topical skin compositions, their preparation, and their use
RU2214818C2 (ru) * 2001-06-08 2003-10-27 Научный Центр Здоровья детей РАМН Лекарственное средство для местного лечения слизистых оболочек и кожи
JP2003212770A (ja) * 2002-01-22 2003-07-30 Ichimaru Pharcos Co Ltd メイラード反応阻害剤
JP4979181B2 (ja) * 2003-01-31 2012-07-18 株式会社ヤクルト本社 グリケーション阻害剤及びその利用
JP2006104098A (ja) * 2004-10-04 2006-04-20 Ichimaru Pharcos Co Ltd ヒアルロニダーゼ活性阻害剤
JP5207611B2 (ja) * 2006-09-29 2013-06-12 小林製薬株式会社 糖化阻害剤

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE888635A (fr) * 1980-04-30 1981-08-17 Zenyaku Kogyo Kk Nouvel extrait de plante, procede de preparation, agent immunostimulant comprenant cet extrait comme composant efficace et immunotherapie par son utilisation,
WO1997042957A1 (fr) * 1996-05-15 1997-11-20 Rio Pharmaceuticals Limited Compositions pharmaceutiques comprenant une xanthine et une catechine
WO2003032969A2 (fr) * 2001-10-15 2003-04-24 National Research Council Of Canada Agents anti-glycation destines a la prevention des complications liees a l'age, au diabete et au tabagisme
JP2003212749A (ja) * 2002-01-16 2003-07-30 Noevir Co Ltd ＡＧＥｓ生成抑制剤及びそれを含有する皮膚外用剤
FR2838054A1 (fr) * 2002-04-04 2003-10-10 Rocher Yves Biolog Vegetale Association d'extraits de plantes pour le traitement de la cellulite
EP1683805A1 (fr) * 2003-10-24 2006-07-26 Meiji Seika Kaisha Ltd. Nouvel inhibiteur de formation de produit terminal de glycation avancee et inhibiteur d'aldose reductase
WO2006078848A1 (fr) * 2005-01-21 2006-07-27 Western Holdings, Llc Compositions contenant des extraits botaniques riches en phlorizine et procedes d'utilisation desdites compositions pour modifier le glucose sanguin et agir sur le viellissement
JP2007119373A (ja) * 2005-10-26 2007-05-17 Arkray Inc メイラード反応生成物分解剤およびそれを用いた飲食品

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
L. GUARALDO ET AL: "Antiulcer action of the hydroalcoholic extract and fractions of Davilla rugosa Poiret in the rat", JOURNAL OF ETHNOPHARMACOLOGY, vol. 76, no. 2, July 2001 (2001-07-01), pages 191 - 195, XP002543582 *
L. GUARALDO ET AL: "Hydroalcoholic extract and fractions of davilla rugosa Poiret: effects on spontaneous motor activity and elevated plus-maze behavior", JOURNAL OF ETHNOPHARMACOLOGY, vol. 72, 2000, pages 61 - 67, XP002543583 *
PAUL URIOS ET AL: "Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure", EUROPEAN JOURNAL OF NUTRITION, STEINKOPFF-VERLAG, DA, vol. 46, no. 3, 13 March 2007 (2007-03-13), pages 139 - 146, XP019516429, ISSN: 1436-6215 *

Also Published As

Publication number Publication date
EP2170307A2 (fr) 2010-04-07
BRPI0813926A2 (pt) 2014-12-30
FR2918569A1 (fr) 2009-01-16
KR20150053817A (ko) 2015-05-18
JP2010533142A (ja) 2010-10-21
CN101686954A (zh) 2010-03-31
CN101686954B (zh) 2015-03-18
US20100316743A1 (en) 2010-12-16
US20130078202A1 (en) 2013-03-28
WO2009007411A2 (fr) 2009-01-15
JP2014088381A (ja) 2014-05-15
FR2918569B1 (fr) 2012-09-28
KR20100042279A (ko) 2010-04-23

Similar Documents

Publication Publication Date Title
WO2009007411A3 (fr) Inhibition de la formation des ages
WO2009155001A3 (fr) Inhibiteurs de signalisation de la protéine wnt
WO2009027820A3 (fr) Composés de pipéridine de type quinoxaline substituée et leurs utilisations
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
WO2009074735A8 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2008097561A8 (fr) Oxabicycloheptanes et oxabicycloheptènes, leur préparation et leur utilisation
WO2007016538A3 (fr) Preparation et utilisation de derives aminoacides biphenyle pour traiter l'obesite
WO2010001169A3 (fr) Composés chimiques 251
WO2007128817A3 (fr) Dérivé insulinique
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
TW200736253A (en) Pyridopyrazine derivatives and their use
WO2008089201A3 (fr) Composés de pipéridine substituée hétérocycliques et leurs utilisations
WO2009085889A3 (fr) Compositions et procédés pour réduire ou empêcher la perte d'eau par la peau
WO2008132021A3 (fr) Mélanges fongicides
WO2009125925A3 (fr) Peptides imitant le facteur de croissance et utilisations de ces derniers
WO2006121522A3 (fr) Capteurs et pompes implantables, agents anticicatrisants, et compositions therapeutiques
WO2009077098A3 (fr) Utilisation de dérivés de guanidine polymères dans la lutte contre des micro-organismes indésirables dans le domaine phytosanitaire
WO2007079312A3 (fr) Compositions et procédés de traitement d’affections pathologiques médiées par l'actine
WO2009011910A3 (fr) Composés d'imidazolidinone, procédés pour inhiber une désubiquitination et procédés de traitement
WO2008066775A3 (fr) Compositions et procédés visant à réduire la graisse et à rétracter la peau
WO2009106555A3 (fr) Gel de sucralfate sterilise
WO2010042212A3 (fr) Méthodes de traitement prophylactique ou thérapeutique de la douleur à l'aide de dérivés de spicamycine
WO2008008468A3 (fr) Compositions et procédés de réduction de la graisse
WO2008050133A3 (fr) Inhibition d'une agrégation de beta-amyloïde

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880022985.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08786012

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2010515507

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2008786012

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008786012

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20107002759

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12667872

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0813926

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20100108

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载